Literature DB >> 31401301

Osteocalcin affects bone mineral and mechanical properties in female mice.

O Berezovska1, G Yildirim1, W C Budell2, S Yagerman3, B Pidhaynyy2, C Bastien1, M C H van der Meulen4, T L Dowd5.   

Abstract

Osteocalcin is one of the most abundant noncollagenous proteins in bone. Phenotypes of osteocalcin knock-out mice (OC-/-) may vary on different backgrounds and with sex. Previous studies using adult female (OC-/-) mice on a mixed genetic background (129/B6) showed osteocalcin inhibited bone formation leading to weaker bone in wild-type (OC+/+). Yet on a pure (B6) genetic background male mice revealed osteocalcin improved fracture resistance and OC-/- bones were more prone to fracture. Osteocalcin is decreased with age and in some diseases (diabetes) where bone weakness is observed. The effect of osteocalcin in adult female bone from mice on a pure B6 background is unknown. We investigated differences in bone mineral properties and bone strength in female adult (6 months) (OC+/+) and (OC-/-) mice on a pure C57BL/6J background using Fourier Transform Infrared Imaging (FTIRI), micro-computed tomography (uCT), biomechanical measurements, histomorphometry and serum turnover markers (P1NP, CTX). Similar to female age matched mice on the (129/C57) background we found B6 OC-/- mice had a higher bone formation rate, no change in bone resorption, more immature mineral, decreased crystallinity and increased trabecular bone as compared to OC+/+. In contrast, the OC-/- mice on a pure B6 background had a lower bone mineral density, lower mineral to matrix ratio resulting in reduced stiffness and weaker bone strength. Our results demonstrate some properties of the OC-/- phenotype are dependent on genetic background. This may suggest that reduced osteocalcin may contribute to fracture and weaker bone in some groups of elderly and adults with diseases where osteocalcin is low.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomechanics; FTIRI; MicroCT; Osteocalcin knock-out mouse

Mesh:

Substances:

Year:  2019        PMID: 31401301      PMCID: PMC8243730          DOI: 10.1016/j.bone.2019.08.004

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  43 in total

Review 1.  Whole bone mechanics and bone quality.

Authors:  Jacqueline H Cole; Marjolein C H van der Meulen
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

2.  PINP: a serum biomarker of bone formation in the rat.

Authors:  L V Hale; R J Sells Galvin; J Risteli; Y L Ma; A K Harvey; X Yang; R L Cain; Q Zeng; C A Frolik; M Sato; A L Schmidt; A G Geiser
Journal:  Bone       Date:  2006-12-22       Impact factor: 4.398

3.  Hierarchical relationship between bone traits and mechanical properties in inbred mice.

Authors:  Karl J Jepsen; Ozan J Akkus; Robert J Majeska; Joseph H Nadeau
Journal:  Mamm Genome       Date:  2003-02       Impact factor: 2.957

4.  The effect of Pb(2+) on the structure and hydroxyapatite binding properties of osteocalcin.

Authors:  T L Dowd; J F Rosen; L Mints; C M Gundberg
Journal:  Biochim Biophys Acta       Date:  2001-02-14

5.  Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.

Authors:  Masami Ishida; Shigeru Amano
Journal:  J Bone Miner Metab       Date:  2004       Impact factor: 2.626

6.  Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli.

Authors:  Toshihiro Sugiyama; Toshiaki Takaki; Kenya Sakanaka; Hiroki Sadamaru; Koji Mori; Yoshihiko Kato; Toshihiko Taguchi; Takashi Saito
Journal:  J Endocrinol       Date:  2007-07       Impact factor: 4.286

7.  Dilatational band formation in bone.

Authors:  Atharva A Poundarik; Tamim Diab; Grazyna E Sroga; Ani Ural; Adele L Boskey; Caren M Gundberg; Deepak Vashishth
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

8.  Fourier transform-infrared microspectroscopy and microscopic imaging.

Authors:  Samuel Gourion-Arsiquaud; Paul A West; Adele L Boskey
Journal:  Methods Mol Biol       Date:  2008

9.  Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue.

Authors:  P V Hauschka; J B Lian; P M Gallop
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

10.  Biomolecular regulation, composition and nanoarchitecture of bone mineral.

Authors:  Atharva A Poundarik; Adele Boskey; Caren Gundberg; Deepak Vashishth
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

View more
  5 in total

Review 1.  Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones.

Authors:  Jialiang S Wang; Courtney M Mazur; Marc N Wein
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-10       Impact factor: 5.555

2.  Dentin Matrix Protein 1 Silencing Inhibits Phosphorus Utilization in Primary Cultured Tibial Osteoblasts of Broiler Chicks.

Authors:  Tingting Li; Yanqiang Geng; Yun Hu; Liyang Zhang; Xiaoyan Cui; Weiyun Zhang; Feiyu Gao; Zongping Liu; Xugang Luo
Journal:  Front Vet Sci       Date:  2022-04-26

Review 3.  Functions of Osteocalcin in Bone, Pancreas, Testis, and Muscle.

Authors:  Toshihisa Komori
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

4.  Supercritical Carbon Dioxide Decellularized Bone Matrix Seeded with Adipose-Derived Mesenchymal Stem Cells Accelerated Bone Regeneration.

Authors:  Keng-Fan Liu; Rong-Fu Chen; Yun-Ting Li; Yun-Nan Lin; Dar-Jen Hsieh; Srinivasan Periasamy; Sin-Daw Lin; Yur-Ren Kuo
Journal:  Biomedicines       Date:  2021-12-03

5.  An osteocalcin-deficient mouse strain without endocrine abnormalities.

Authors:  Cassandra R Diegel; Steven Hann; Ugur M Ayturk; Jennifer C W Hu; Kyung-Eun Lim; Casey J Droscha; Zachary B Madaj; Gabrielle E Foxa; Isaac Izaguirre; Vai Vivarium And Transgenics Core; Noorulain Paracha; Bohdan Pidhaynyy; Terry L Dowd; Alexander G Robling; Matthew L Warman; Bart O Williams
Journal:  PLoS Genet       Date:  2020-05-28       Impact factor: 6.020

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.